Skip to search formSkip to main contentSkip to account menu

ID Rhabdomyosarcoma Regimen

Known as: ID Regimen, IRS-IV ID Regimen, Ifosfamide-Doxorubicin Rhabdomyosarcoma Regimen 
A regimen consisting of ifosfamide and doxorubicin used for the treatment of high-risk childhood rhabdomyosarcoma.
National Institutes of Health

Related topics

Related topics

3 relations
DoxorubicinIfosfamidechildhood rhabdomyosarcoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
The challenge to provide affordable rabies post-exposure treatment.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)